PARP inhibitors target triple-negative, BRCA1/2 cancers: Commentary

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalOncology Report
Issue numberFALL
StatePublished - Sep 1 2009

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this